Iwakura Takamasa, Ohashi Naro, Kato Akihiko, Baba Satoshi, Yasuda Hideo
Internal Medicine I, Division of Nephrology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Blood Purification Unit, Hamamatsu University School of Medicine, Hamamatsu, Japan.
PLoS One. 2015 Sep 22;10(9):e0138841. doi: 10.1371/journal.pone.0138841. eCollection 2015.
Membranous nephropathy (MN) is a leading cause of nephrotic syndrome in adults. Autoantibodies against M-type phospholipase A2 receptor (PLA2R) and thrombospondin type-1 domain-containing 7A (THSD7A), which mainly belong to the IgG4 subclass, were reported as associated antibodies for the development of MN. Although PLA2R is a major target antigen for idiopathic MN, the prevalence of MN patients seropositive for PLA2R in Japan is lower than that in other countries. In this study, we conducted immunohistochemical analysis of the presence of THSD7A and PLA2R in renal specimens of MN patients to estimate the prevalence of THSD7A/PLA2R-related idiopathic MN in Japan. Enhanced granular expression of THSD7A and PLA2R was detected in 9.1% and 52.7%, respectively, of the patients with idiopathic MN. Although none of patients with secondary MN displayed enhanced granular expression of THSD7A, 5.4% of them had enhanced granular expression of PLA2R. In conclusion, the prevalence of enhanced granular expression of THSD7A in the glomeruli of Japanese patients with idiopathic MN was higher than the prevalence of MN patients seropositive for THSD7A in USA and Europe.
膜性肾病(MN)是成人肾病综合征的主要病因。抗M型磷脂酶A2受体(PLA2R)和含血小板反应蛋白1型结构域7A(THSD7A)的自身抗体主要属于IgG4亚类,被报道为MN发病的相关抗体。尽管PLA2R是特发性MN的主要靶抗原,但在日本,PLA2R血清学阳性的MN患者患病率低于其他国家。在本研究中,我们对MN患者肾脏标本中THSD7A和PLA2R的存在情况进行了免疫组织化学分析,以评估日本THSD7A/PLA2R相关特发性MN的患病率。在特发性MN患者中,分别有9.1%和52.7%检测到THSD7A和PLA2R的颗粒表达增强。虽然继发性MN患者均未表现出THSD7A颗粒表达增强,但其中5.4%有PLA2R颗粒表达增强。总之,日本特发性MN患者肾小球中THSD7A颗粒表达增强的患病率高于美国和欧洲THSD7A血清学阳性的MN患者患病率。